Masonic Italian e-Journal: Eris has arrived in Italy

Editor’s Note: Fanpage.it in response to the online outcry of Italians against another plandemic, has chosen to run a story about the Eris ‘variant’ in a vain attempt to make people believe in this new mythical creature. It warns readers that this horrible ‘virus’ can give you some of the symptoms of the regular cold!

FanPage’s “report” regurgitates public statements by Globalist controlled “health” organizations such as the W.H.O. and various entities created to push the narrative that variants of the mythical SarsCo2 exist.

According to its Wikipedia article, Fanpage.It is a media outlet of recent foundation, at Naples, Italy, in 2011, which has been used by the United Nations to promote a campaign against criminality.

In Italian, “Fan” has the same popular sense as in English. But it is not clear what kind of fans, FanPage.it seems to address itself to. Maybe sheeple?

With Globalist Censorship growing daily, No one will ever know about the above article, if you do not share it.

2 thoughts on “Masonic Italian e-Journal: Eris has arrived in Italy”

  1. I was in the hospital for 3 months (ICU, Therapy and then one month to recover etc.) due to COVID. It took 4 tries to “detect” it and at that time I was almost recovering from what was a bad flu but they said I had pneumonia and intubated my lungs. The more I think of it, the more I am convinced that the treatment was worse than the infirmity. I won’t fall for it again.
    Variant shvariant! We see the man behind the curtain.

    1. Non Preavalebunt: according to the data collected by Gianfranco Tajana, the statistic was 1 surviver over 9 death (NY hospitals) among intubated (page 5).
      https://www.versonondove.com/wp-content/uploads/2020/10/1-APC_01.pdf

      Meteoweb
      https://www.meteoweb.eu/2020/06/covid-19-coagulopatia-trombosi-autopsie-lombardia/1443983/

      The Lancet: THROMBOTIC VASCULAR INVOLVEMENT” (GO and the effects of EMR)
      “[…] diffuse thrombotic vascular involvement. This latter finding could be relevant in the management and targeted treatment of patients infected with SARS-CoV-2, with the potential to modify outcomes.”
      https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30434-5/fulltext?fbclid=IwAR01wGaXz6Px5Vr0oM4Z0xRNJd9KhggGyCgIwBBaXfIaghtYIt97KEIi6ns#seccestitle130

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.